View in EDS

Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial.

Saved in:

Bibliographic Details
Title:	Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial.
Authors:	Caparica, Rafael, Yaohua Ma, Angelis, Claudia De, Richard, François, Desmedt, Christine, Awada, Ahmad, Piccart, Martine, Perez, Edith A., Moreno-Aspitia, Alvaro, Badve, Sunil, Thompson, E. Aubrey, Azambuja, Evandro de, Ma, Yaohua, De Angelis, Claudia, de Azambuja, Evandro
Source:	Clinical Breast Cancer; Jun2022, Vol. 22 Issue 4, p308-318, 11p
Database:	Complementary Index

Description
ISSN:	15268209
DOI:	10.1016/j.clbc.2021.11.012